About Nebu~Flow
Nebu~Flow is a company based in Glasgow (United Kingdom) founded in 2019 by Julien Reboud. Nebu~Flow has raised $7.97 million across 3 funding rounds from investors including Ascension, Scottish Enterprise and Williams Advanced Engineering. Nebu~Flow offers products and services including Nebu-Flow Nebuliser. Nebu~Flow operates in a competitive market with competitors including MannKind Corp, OptiNose, Impel NeuroPharma, Alexza and Qnovia, among others.
- Headquarter Glasgow, United Kingdom
- Founders Julien Reboud
- SectorsHealthcare
- Email••••••••
- Website nebuflow.com
- Social LinkedIn X Facebook
- Legal Name Acu-Flow Limited
- Date of Incorporation 14 Mar, 2019
- Jurisdiction GLASGOW, UNITED KINGDOM
- Total Equity Funding$7.97M (USD)
in 3 rounds
- Latest Funding Round$5.87M (USD), Series A
Apr 2024
- InvestorsAscension
& 9 more
Products & Services of Nebu~Flow
Nebu~Flow offers a comprehensive portfolio of products and services, including Nebu-Flow Nebuliser.
Enables efficient inhalation delivery of hard-to-nebulise respiratory drugs.
Funding Insights of Nebu~Flow
Nebu~Flow has successfully raised a total of $7.97M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $5.87 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $7.97M
- Total Rounds 3
- Last Round Series A — $5.87M
- First Round $2.09M
(May 2022)
- Investors Count 10
All 3 funding rounds of NebuFlow with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2024 | $5.87M | Series A | – | SCVC | |
| Aug 2022 | $1.21M | Grant | – | – | |
| May 2022 | $2.09M | Seed | – | Foresight Group |
10 investors in total: 10 institutional.
Investors in Nebu~Flow
Nebu~Flow has secured backing from 10 investors, including institutional and venture fund investors. Prominent investors backing the company include Ascension, Scottish Enterprise and Williams Advanced Engineering.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Science Creates is recognized as a Deep Tech ecosystem supporting startups. | – | sciencecreates.co.uk | Bristol, United Kingdom | |
Ascension is recognized as a venture capital firm focused on early-stage tech investments. | – | ascension.vc | London, United Kingdom | |
Venture capital fund focused on social impact companies | – | sisventures.com | Edinburgh, United Kingdom | |
Early-stage venture capital investments in deep tech are facilitated. | – | scvc.com | Bristol, United Kingdom | |
Venture capital is provided to impact-driven startups. | – | theconduitconnect.com | London, United Kingdom | |
The BioIndustry Association is recognized as the voice of the UK’s innovative life sciences and biotech industry. | – | bioindustry.org | London, United Kingdom | |
Foresight Group is engaged in sustainable investment management. | 1984 | foresightgroup.eu | - | |
Business development and leadership training programs are offered to companies. | 1991 | scottish-enterprise.com | Glasgow, United Kingdom | |
Battery management systems for electric vehicles are provided. | 2010 | wae.com | Wantage, United Kingdom | |
Health systems are operated nationwide by Ascension. | 1999 | ascension.org | St. Louis, United States |
Investor details for NebuFlow
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Nebu~Flow
2 people are tracked at Nebu~Flow (1 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Julien Reboud | Co-Founder | Leadership |
Elijah Nazarzadeh | Building Next Generation Of Nebulisers | Team |
Complete people profiles for Nebu~Flow
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Nebu~Flow
3 dated milestones of Nebu~Flow across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Nebu~Flow is founded.
- Funding First funding round of $2.1M.
- Funding Latest funding round, Series A, of $5.9M.
Competitors of Nebu~Flow
Nebu~Flow operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MannKind Corp, OptiNose, Impel NeuroPharma, Alexza and Qnovia, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| mannkindcorp.com | 1991 | Los Angeles, United States | $50M | 322 | Developer of small-molecule drugs | |
| optinose.com | 2000 | Morrisville, United States | $120.5M | 132 | Developer of smart devices for nasal drug delivery | |
| impelnp.com | 2008 | Seattle, United States | $126.83M | 158 | Intranasal delivery technology for CNS diseases is developed. | |
| alexza.com | 2000 | Mountain View, United States | $97M | 72 | Developer of products for the treatment of acute and intermittent conditions | |
| qnovia.com | 2018 | Richmond, United States | $38.12M | – | Inhaled drug delivery devices are developed for pharmaceuticals. | |
| iconovo.se | 2013 | Lund, Sweden | $3.56M | – | Inhalation devices for medical applications are developed by Iconovo. | |
| aerami.com | 2010 | Durham, United States | $151.1M | – | Therapeutics for cardiopulmonary diseases are developed using inhaled therapies. | |
| nobhilltherapeutics.com | 2016 | Albuquerque, United States | $3.67M | – | Dry powder nebulizer is developed for targeted lung drug delivery. | |
| beyondair.net | 2011 | Garden, United States | – | – | Developer of device for treating respiratory conditions |
Detailed competitors of NebuFlow
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Nebu~Flow
The website of Nebu~Flow (nebuflow.com) receives about 1.5K visits a month.
- Monthly visits1.5K
▼ 59.7% vs previous month
Latest news on Nebu~Flow
Complete news archive for NebuFlow
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Nebu~Flow
10 companies that operate in the same segment as Nebu~Flow (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Nebu~Flow
Nebu~Flow was founded in 2019 and raised its 1st funding round 3 years after it was founded.
Nebu~Flow is headquartered in Glasgow, United Kingdom. It is registered at Glasgow, Scotland, United Kingdom.
Nebu~Flow is a funded company, having raised a total of $7.97M across 3 funding rounds to date. The company's 1st funding round was a Seed of $2.09M, raised on May 2022.
NebuFlow was established in 2019 in Glasgow, United Kingdom, as a developer of aerosol delivery platform technology within the health tech sector. The companys operations focus on creating innovative platforms for precise aerosol administration, targeting respiratory and inhalation therapies. Services encompass research, prototyping, and platform integration for pharmaceutical and medical device applications. Leadership includes co-founder Julien Reboud, with activities centered in the UK.
Nebu~Flow's top competitors include MannKind Corp, OptiNose and Impel NeuroPharma.
Nebu~Flow offers Nebu-Flow Nebuliser.
Nebu~Flow has 10 investors. Key investors include Ascension, Scottish Enterprise, Williams Advanced Engineering, BioIndustry Association, and Foresight Group.
Nebu~Flow operates through Acu-Flow Limited.